The AI in Life Sciences series brings together Husch Blackwell attorneys from multiple practice areas to provide practical, business‑focused guidance on the most pressing legal issues surrounding artificial intelligence in the life sciences and healthcare industries. Across five webinars, the series addresses a wide range of AI‑related legal considerations. Whether you’re negotiating agreements, evaluating acquisitions, protecting innovations through patents and copyrights, or developing AI policies, this series offers the insights you need to navigate AI with confidence.
The third webinar in the series explores how artificial intelligence is reshaping all industries, including the life sciences industry, from drug discovery and development to research and commercialization. This webinar examines how AI-enabled innovations can be protected through patents, focusing on Section 101 patent eligibility considerations and recent USPTO guidance. Through real-world examples across multiple domains, our presenters will illustrate how AI-based technologies can be protected in the patent space. Learn practical strategies for evaluating AI inventions, identifying patentable innovations, and crafting stronger patent applications positioned for success in an evolving legal landscape.
Presenters
Bryan Stewart, Partner
Paige Reese, Senior Associate
Who Should Attend
General counsel, in-house IP counsel, entrepreneurs
Continuing Education Credit
This program is pending approval for California, Colorado, Illinois, Iowa, Kansas, Missouri, Minnesota, Nebraska, Pennsylvania, Tennessee, Texas, and Wisconsin continuing legal education credit.
Did You Miss the Webinar?
The webinar recording is available after the event date. Simply register using this on-demand link to access the recorded program.